We sold our remaining Alcon shares to Novartis and acquired Kraft Foods’ frozen pizza business.
We faced a challenge from Greenpeace who wanted to be reassured about our commitment to sustainable Palm Oil. It was the first time we saw social media being used in a substantial way to challenge us and ask questions. We didn’t get the handling of our response to the campaign itself quite right in social media, but on the issue at its heart – palm oil - we took steps to both strengthen our position and to explain it more clearly.
We launched the Nestlé Cocoa Plan which supplies high quality, disease-resistant plantlets to farmers helping them rejuvenate their farms and increase productivity. The Nescafé Plan was also launched – to address responsible farming, sourcing and consumption across our coffee supply chain.
We announced the creation of Nestlé Health Science and the Nestlé Institute of Health Sciences, innovative ventures aimed at the prevention and eventually treatment of chronic medical conditions with science-based personalised nutrition solutions.
We voluntarily submitted our policies and procedures to the FTSE4Good Policy Committee for independent review and became the first infant formula manufacturer to be included in the FTSE4Good Index. This is the London Stock Exchanges’s responsible investment index and the only index that evaluates companies on their responsible marketing of breast-milk substitutes, alongside human rights and supply chain criteria.
China was at the forefront, as we announced partnerships with the Chinese food companies Yinlu, a manufacturer of ready-to-drink peanut milk and canned rice porridge and with Hsu Fu Chi, a confectionery and snacks manufacturer.
We became the first food company to partner with the Fair Labor Association. This partnership will help us investigate if children are working in cocoa farms that supply our factories and, where we find problems, to solve them.
Nestlé Health Science S.A acquired Prometheus Laboratories Inc., a US-based company specialised in diagnostics and in-licensed specialty pharmaceuticals in gastroenterology and oncology. It also acquired a minority stake in Vital Foods, a New Zealand based company that specialises in the development of kiwifruit- based solutions for gastrointestinal conditions.
We acquired Wyeth Nutrition (Pfizer Nutrition) in a strategic move to enhance our position in global infant nutrition.
Nestlé Health Science acquired Pamlab, a US-based company with an innovative portfolio of medical food products for use under medical supervision in the nutritional management of patients with mild cognitive impairment, depression and diabetic peripheral neuropathy.
We divested Jenny Craig businesses in North America and Oceania to North Castle Partners.
We extended our activities to include the field of specialised, medical skin treatments through the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world’s increasing skin health needs with a broad range of innovative and scientifically-proven products. Nestlé Skin Health S.A. is managed as a wholly-owned Nestlé subsidiary with its own Board of Directors and headquarters located in Lausanne.
We divested PowerBar to Post Holdings.
All our news can be found in the News archive section.